Telehealth Intake Red Flags: What the Secret Shopper Study Taught Us to Watch For
Seven specific patterns that identify poor-quality GLP-1 intake processes — drawn directly from what the Yale study found — alongside the green flags that indicate responsible prescribing.
The Yale secret shopper study gave us data on what bad telehealth intake looks like at scale. Here's how to translate those findings into a practical checklist of red flags to watch for when you're evaluating a GLP-1 telehealth platform.
Only 32.7% of the 49 platforms in the Yale study had documented clinician interaction before prescribing. The remaining 67.3% — the red flag category — are the patterns to learn to recognize.
Red flags in the intake process
- Prescription approval email arrives within minutes of intake submission. No human review takes minutes — if you completed a 5-minute questionnaire and received approval in 8 minutes, the probability of real clinician review is low.
- No mention of who will review your intake. The platform should tell you a licensed provider will review your information. Generic "our medical team" language without specifics is a yellow flag.
- No lab requirements for a first GLP-1 prescription. Platform-appropriate labs are standard of good practice. Skip-the-labs initiation is a flag for inadequate screening.
- Intake that doesn't ask about thyroid history or family history of MTC. The GLP-1 boxed warning covers medullary thyroid carcinoma risk. Any responsible intake asks.
- Intake that doesn't ask about pancreatitis history. Active pancreatitis is a contraindication. An intake without this question didn't screen for it.
- Payment required before any provider review. You shouldn't be charged before your intake is clinically reviewed — paying before review signals automation rather than clinical care.
- No information about follow-up. A legitimate prescription model includes a follow-up protocol. Prescription-and-disappear is the pattern the study identified most frequently.
Green flags (what you want to see)
Positive intake signals
- Specific prescriber name and license number provided before or with prescription
- Intake that explicitly asks about thyroid, pancreatitis, and current medications
- Lab requirements communicated before payment
- Follow-up protocol described explicitly (timing, format, what triggers a check-in)
- Review timeframe stated: 'a licensed provider will review within X hours'
- Ability to message the clinical team with questions before prescription is issued
Verified telehealth providers
Passes every green flag. Documented physician review, labs included, structured follow-up.
Paid link Get started →Provider-first intake process — documentation before prescription.
Paid link Get started →Real provider visit — clinician interaction is the product, not a checkbox.
Paid link Get started →